Immediate attention is paramount for addressing the escalating prevalence of severe insulin resistance during pregnancy. A collaborative and multidisciplinary approach involving clinical care, public health initiatives and advanced technologies is essential for enhancing care, improving maternal and fetal outcomes, and mitigating long-term metabolic risks.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$32.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$189.00 per year
only $15.75 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Lin, J., Jin, H. & Chen, L. Associations between insulin resistance and adverse pregnancy outcomes in women with gestational diabetes mellitus: a retrospective study. BMC Pregnancy Childbirth 21, 526 (2021).
McIntyre, H. D., Catalano, P., Zhang, C., Desoye, G., Mathiesen, E. R. & Damm, P. Gestational diabetes mellitus. Nat. Rev. Dis. Primers 5, 47 (2019).
Catalano, P. M. Trying to understand gestational diabetes. Diabet. Med. 31, 273–281 (2014).
Ategbo, J. M. et al. Modulation of adipokines and cytokines in gestational diabetes and macrosomia. J. Clin. Endocrinol. Metab. 91, 4137–4143 (2006).
Lowe, W. L., Scholtens, D. M., Sandler, V. & Hayes, M. G. Genetics of gestational diabetes mellitus and maternal metabolism. Curr. Diab. Rep. 16, 15 (2016).
American Diabetes Association Professional Practice Committee. Standards of care in diabetes—2025. Diabetes Care 48, Suppl. 1 (2025).
Lee, T. T. M. et al. AiDAPT Collaborative Group. Automated insulin delivery in women with pregnancy complicated by type 1 diabetes. N. Engl. J. Med. 389, 1566–1578 (2023).
Benhalima, K. et al. Comparing advanced hybrid closed loop therapy and standard insulin therapy in pregnant women with type 1 diabetes (CRISTAL): a parallel-group, open-label, randomised controlled trial. Lancet Diabetes Endocrinol. 12, 390–403 (2024).
Lloyd, M. et al. Long-term cost-effectiveness of implementing a lifestyle intervention during pregnancy to reduce the incidence of gestational diabetes and type 2 diabetes. Diabetologia 66, 1223–1234 (2023).
Valent, A. M. & Barbour, L. A. Insulin management for gestational and type 2 diabetes in pregnancy. Obstet. Gynecol. 144, 633–647 (2024).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Rights and permissions
About this article
Cite this article
Young, C.F., Isaacs, D. A call for a multidisciplinary intervention to address severe insulin resistance during pregnancy. Nat Rev Endocrinol 21, 586–587 (2025). https://doi.org/10.1038/s41574-025-01164-2
Published:
Issue date:
DOI: https://doi.org/10.1038/s41574-025-01164-2